Identification
A: Thin-Layer Chromatographic Identification Test 201
Test solution
Transfer a portion of Capsule contents, equivalent to about 120 mg of rifampin, to a suitable flask, add 20 mL of methanol, and shake for several minutes. Pass this suspension through a filter having a 1-µm or finer porosity, discarding the first few mL of the filtrate. Dilute a volume of the filtrate with an equal volume of acetone, and mix.
Standard solutions
Dissolve a quantity of
USP Rifampin RS in methanol to obtain a solution containing 6 mg per mL. Add an equal volume of acetone, and mix. Dissolve a quantity of
USP Isoniazid RS in methanol to obtain a solution containing 2.5 mg per mL. Add an equal volume of acetone, and mix.
Application volume:
2 µL.
Developing solvent solution:
a mixture of acetone and glacial acetic acid (100:1).
B:
The retention times of the rifampin and isoniazid peaks in the chromatogram of the Assay preparation correspond to those of rifampin and isoniazid in the chromatogram of the Standard preparation, as obtained in the Assay for rifampin and isoniazid.
Dissolution 711
Medium:
0.1 N hydrochloric acid; 900 mL.
Apparatus 1:
100 rpm.
Time:
45 minutes.
Determine the amount of rifampin (C43H58N4O12) dissolved by employing the following method.
Phosphate buffer solution
Dissolve 15.3 g of dibasic potassium phosphate and 80.0 g of monobasic potassium phosphate into a 1-L volumetric flask, mix, dilute with water to volume, and mix.
Isoniazid standard solution
Accurately weigh about 66 mg of
USP Isoniazid RS into a 100-mL volumetric flask. Dissolve in and dilute with 0.1 N hydrochloric acid to volume, and mix.
Standard stock solution
Accurately weigh about 66 mg of
USP Rifampin RS into a 200-mL volumetric flask, dissolve in 10 mL of 0.1 N hydrochloric acid, and mix. Add 50.0 mL of
Isoniazid standard solution, dilute with 0.1 N hydrochloric acid to volume, and mix.
[NOTEPrepare this solution immediately before the test is performed, and place in the dissolution bath at the start of the test.
]
Standard solution
At the end of the test run, transfer a 5.0-mL aliquot of the Standard stock solution and 10.0 mL of Phosphate buffer solution to a 50-mL volumetric flask. Dilute with water to volume, and mix. [NOTEAnalyze the solution immediately, if possible, and if not, within 3 hours after final dilution.]
Test solution
At the end of the test run, withdraw a 25-mL aliquot, and filter, discarding the first 10 mL of the filtrate. Allow to cool for about 10 minutes, and transfer 5.0 mL of the filtrate and 10.0 mL of the Phosphate buffer solution to a 50-mL volumetric flask. Dilute with water to volume, and mix. [NOTEAnalyze the solution immediately, if possible, and if not, within 3 hours after final dilution.]
Determine the amount of rifampin (C43H58N4O12) dissolved from absorbances at the wavelength of maximum absorbance at about 475 nm of the Standard solution and the Test solution.
Determine the amount of isoniazid (C6H7N3O) dissolved by employing the following method.
Mobile phase
Prepare a filtered and degassed mixture of water,
Phosphate buffer solution, and methanol (850:100:50). Make adjustments if necessary (see
System Suitability under
Chromatography 621).
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 254-nm detector and a 4.0-mm × 30-cm column that contains 10-µm packing L1. The flow rate is about 1.5 mL per minute.
Procedure
Separately inject equal volumes (about 50 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the isoniazid peaks.
Tolerances
Not less than 75% (Q) of the labeled amount of C43H58N4O12 and not less than 80% (Q) of the labeled amount of C6H7N3O are dissolved in 45 minutes.
Assay for rifampin and isoniazid
Buffer solution
Dissolve 1.4 g of dibasic sodium phosphate in 1 L of water, and adjust with phosphoric acid to a pH of 6.8.
Solution A
Prepare a filtered and degassed mixture of Buffer solution and acetonitrile (96:4).
Solution B
Prepare a filtered and degassed mixture of acetonitrile and Buffer solution (55:45).
Mobile phase
Use variable mixtures of
Solution A and
Solution B as directed for
Chromatographic system. Make adjustments if necessary (see
System Suitability under
Chromatography 621).
Standard preparation
Dissolve accurately weighed quantities of
USP Rifampin RS and
USP Isoniazid RS in a mixture of
Buffer solution and methanol (96:4) to obtain a solution having known concentrations of about 0.16 mg per mL and 0.08 mg per mL, respectively.
[NOTEUse this solution within 10 minutes.
]
Assay preparation
Weigh the contents of not fewer than 10 Capsules, mix, and transfer an accurately weighed portion of the powder, equivalent to about 8 mg of isoniazid, to a 100-mL volumetric flask, and add about 90 mL of Buffer solution. Sonicate for about 10 minutes, allow to equilibrate to room temperature, dilute with Buffer solution to volume, and mix. [NOTEUse this solution within 2 hours.]
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 238-nm detector and a 4.6-mm × 25-cm column that contains 5-µm base-deactivated packing L1. The flow rate is about 1.5 mL per minute. The chromatograph is programmed as follows.
Time (minutes) |
Solution A
(%) |
Solution B
(%) |
Elution |
0 |
100 |
0 |
equilibration |
05 |
100 |
0 |
isocratic |
56 |
100®0 |
0®100 |
linear gradient |
615 |
0 |
100 |
isocratic |
Chromatograph the
Standard preparation, and record the peak responses as directed for
Procedure: the relative retention times are about 2.6 and 1.0 for rifampin and isoniazid, respectively; the column efficiency is not less than 50,000 and not less than 6,000 theoretical plates for rifampin and isoniazid, respectively; the tailing factors are not more than 2.0; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 20 µL) of the
Standard preparation and the
Assay preparation into the chromatograph, record the chromatograms, and measure the peak responses. Calculate the quantity, in mg, of rifampin (C
43H
58N
4O
12) and isoniazid (C
6H
7N
3O) in the portion of Capsules taken by the formula:
100C(rU / rS),
in which
C is the concentration, in mg per mL, of
USP Rifampin RS, calculated on the dried basis, or of
USP Isoniazid RS, as appropriate, in the
Standard preparation; and
rU and
rS are the peak responses obtained from the corresponding analytes obtained from the
Assay preparation and the
Standard preparation, respectively.